Answers are grounded in this paper and cite their sources.
T cells. Together, these findings identify SOCS1 as a major intracellular negative checkpoint of adoptive T cell response, opening new possibilities to optimize CAR-T cell therapy composition and efficacy.
No takes yet. Share an insight, caveat, or question.
Galy et al. (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: